BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 19759193)

  • 1. Selenium modifies the osteoblast inflammatory stress response to bone metastatic breast cancer.
    Chen YC; Sosnoski DM; Gandhi UH; Novinger LJ; Prabhu KS; Mastro AM
    Carcinogenesis; 2009 Nov; 30(11):1941-8. PubMed ID: 19759193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastatic breast cancer induces an osteoblast inflammatory response.
    Kinder M; Chislock E; Bussard KM; Shuman L; Mastro AM
    Exp Cell Res; 2008 Jan; 314(1):173-83. PubMed ID: 17976581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastatic breast cancer cells suppress osteoblast adhesion and differentiation.
    Mercer RR; Miyasaka C; Mastro AM
    Clin Exp Metastasis; 2004; 21(5):427-35. PubMed ID: 15672867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoblasts are a major source of inflammatory cytokines in the tumor microenvironment of bone metastatic breast cancer.
    Bussard KM; Venzon DJ; Mastro AM
    J Cell Biochem; 2010 Dec; 111(5):1138-48. PubMed ID: 20683902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of versican G3 domain in regulating breast cancer cell motility including effects on osteoblast cell growth and differentiation in vitro - evaluation towards understanding breast cancer cell bone metastasis.
    Du WW; Fang L; Yang W; Sheng W; Zhang Y; Seth A; Yang BB; Yee AJ
    BMC Cancer; 2012 Aug; 12():341. PubMed ID: 22862967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastatic breast cancer cells inhibit osteoblast differentiation through the Runx2/CBFβ-dependent expression of the Wnt antagonist, sclerostin.
    Mendoza-Villanueva D; Zeef L; Shore P
    Breast Cancer Res; 2011 Oct; 13(5):R106. PubMed ID: 22032690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathway.
    Katanov C; Lerrer S; Liubomirski Y; Leider-Trejo L; Meshel T; Bar J; Feniger-Barish R; Kamer I; Soria-Artzi G; Kahani H; Banerjee D; Ben-Baruch A
    Stem Cell Res Ther; 2015 May; 6(1):87. PubMed ID: 25928089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoblasts-derived TGF-beta1 enhance motility and integrin upregulation through Akt, ERK, and NF-kappaB-dependent pathway in human breast cancer cells.
    Wei YY; Chen YJ; Hsiao YC; Huang YC; Lai TH; Tang CH
    Mol Carcinog; 2008 Jul; 47(7):526-37. PubMed ID: 18161870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer bone metastases are attenuated in a Tgif1-deficient bone microenvironment.
    Haider MT; Saito H; Zarrer J; Uzhunnumpuram K; Nagarajan S; Kari V; Horn-Glander M; Werner S; Hesse E; Taipaleenmäki H
    Breast Cancer Res; 2020 Apr; 22(1):34. PubMed ID: 32272947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caffeic acid phenethyl ester protects mice from lethal endotoxin shock and inhibits lipopolysaccharide-induced cyclooxygenase-2 and inducible nitric oxide synthase expression in RAW 264.7 macrophages via the p38/ERK and NF-kappaB pathways.
    Jung WK; Choi I; Lee DY; Yea SS; Choi YH; Kim MM; Park SG; Seo SK; Lee SW; Lee CM; Park YM; Choi IW
    Int J Biochem Cell Biol; 2008; 40(11):2572-82. PubMed ID: 18571461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-inflammatory and antitumoural effects of Uncaria guianensis bark.
    Urdanibia I; Michelangeli F; Ruiz MC; Milano B; Taylor P
    J Ethnopharmacol; 2013 Dec; 150(3):1154-62. PubMed ID: 24212077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological evidence for the bone-autonomous contribution of the NFκB/β-catenin axis to breast cancer related osteolysis.
    Marino S; Bishop RT; Logan JG; Mollat P; Idris AI
    Cancer Lett; 2017 Dec; 410():180-190. PubMed ID: 28965856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bis-(3-hydroxyphenyl) diselenide inhibits LPS-stimulated iNOS and COX-2 expression in RAW 264.7 macrophage cells through the NF-kappaB inactivation.
    Shin KM; Shen L; Park SJ; Jeong JH; Lee KT
    J Pharm Pharmacol; 2009 Apr; 61(4):479-86. PubMed ID: 19298695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-supportive and osteoclastogenic changes induced by breast cancer-derived factors are reversed by inhibition of {gamma}-secretase.
    Fong JE; Le Nihouannen D; Komarova SV
    J Biol Chem; 2010 Oct; 285(41):31427-34. PubMed ID: 20679341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of osteoprotegerin and RANK ligand in breast cancer bone metastasis.
    Park HR; Min SK; Cho HD; Kim DH; Shin HS; Park YE
    J Korean Med Sci; 2003 Aug; 18(4):541-6. PubMed ID: 12923331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoblasts are "educated" by crosstalk with metastatic breast cancer cells in the bone tumor microenvironment.
    Kolb AD; Shupp AB; Mukhopadhyay D; Marini FC; Bussard KM
    Breast Cancer Res; 2019 Feb; 21(1):31. PubMed ID: 30813947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression of osteoclastogenesis-associated factors and osteoblast response to osteolytic prostate cancer cells.
    Morrissey C; Lai JS; Brown LG; Wang YC; Roudier MP; Coleman IM; Gulati R; Vakar-Lopez F; True LD; Corey E; Nelson PS; Vessella RL
    Prostate; 2010 Mar; 70(4):412-24. PubMed ID: 19866469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monotropein attenuates ovariectomy and LPS-induced bone loss in mice and decreases inflammatory impairment on osteoblast through blocking activation of NF-κB pathway.
    He YQ; Yang H; Shen Y; Zhang JH; Zhang ZG; Liu LL; Song HT; Lin B; Hsu HY; Qin LP; Han T; Xin HL; Zhang QY
    Chem Biol Interact; 2018 Aug; 291():128-136. PubMed ID: 29908987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical application of glycolic acid suppresses the UVB induced IL-6, IL-8, MCP-1 and COX-2 inflammation by modulating NF-κB signaling pathway in keratinocytes and mice skin.
    Tang SC; Liao PY; Hung SJ; Ge JS; Chen SM; Lai JC; Hsiao YP; Yang JH
    J Dermatol Sci; 2017 Jun; 86(3):238-248. PubMed ID: 28330776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. α-Linolenic Acid Inhibits Receptor Activator of NF-κB Ligand Induced (RANKL-Induced) Osteoclastogenesis and Prevents Inflammatory Bone Loss via Downregulation of Nuclear Factor-KappaB-Inducible Nitric Oxide Synthases (NF-κB-iNOS) Signaling Pathways.
    Song J; Jing Z; Hu W; Yu J; Cui X
    Med Sci Monit; 2017 Oct; 23():5056-5069. PubMed ID: 29061958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.